Treatment of Cachexia With Ghrelin in Patients With COPD

Slides:



Advertisements
Similar presentations
Volume 128, Issue 6, Pages (December 2005)
Advertisements

Volume 34, Issue 2, Pages (August 1958)
Tell-tale Telangiectasias
Colloquium on Therapy of Right Heart Failure
Volume 97, Issue 3, Pages (March 1990)
Volume 74, Issue 5, Pages (November 1978)
An Unusual Cause of Stridor and Progressive Shortness of Breath
When to Be Rash About a Fever and Headache
Right-Sided Chest Pain with Progressive Dyspnea
Volume 56, Issue 1, Pages (July 1969)
Volume 102, Issue 3, Pages (September 1992)
Volume 110, Issue 3, Pages (September 1996)
Epidemiology and Treatment of Lung Cancer in Seattle
Bovine Tuberculosis Eradication
Volume 133, Issue 4, Pages (April 2008)
Robert Pickering, M.D, Fernando J. Martinez, M.D  CHEST 
Hyperbaric Oxygenation in Cardiac and Pulmonary Disease
Treatment of Sarcoidosis With Infliximab
Volume 128, Issue 3, Pages (September 2005)
Air Pollution and Chest Disease
Navin K. Jain, MD, Thiam H. Lie, MD, FCCP  CHEST 
Clinical and Personality Profiles and Survival in Patients With COPD
The Effects of Helium-Hyperoxia on 6-min Walking Distance in COPD
Fever, Skin Eruption, Low Serum Gammaglobulin in a Child with Leukemia
Oxygen Therapy Titrated to Raise Mixed Venous Oxygen Content in COPD
Volume 107, Issue 5, Pages (May 1995)
Volume 112, Issue 3, Pages (September 1997)
Volume 113, Issue 4, Pages (April 1998)
Treatment of Malignant Pleural Effusion
The Therapeutic Potential of Hyaluronan in COPD
Zaid J. Yaqoob, MD, Sadeer G. Al-Kindi, MD, Joe G. Zein, MD  CHEST 
Precision Medicine Urgency
Disseminated Histoplasmosis Treated with Amphotericin B
Has the 6-Min Walk Distance Run Its Course?
Counterpoint: Adherence to Early Goal-Directed Therapy
Global Physiology and Pathophysiology of Cough
Airway Stenting for Patients With Benign Airway Disease and the Food and Drug Administration Advisory  Lund Mark E. , MD, FCCP, Force Seth , MD, FCCP 
Decortication after 35 Years
Plication for Diaphragmatic Eventration
PEEP, Auto-PEEP, and Waterfalls
Sundeep Salvi, MD, DNB, PhD, FCCP, Peter J. Barnes, DM, FCCP  CHEST 
Counterpoint: Should All ICU Patients Receive Continuous Sedation? No
Situs Inversus Totalis and Lung Cancer
Evaluation of Serum Theophylline Measurement using a Test-strip
Point: Adherence to Early Goal-Directed Therapy
Imaging for the Management of Community-Acquired Pneumonia
Possible Role of Statins in COPD-Related Pulmonary Hypertension
Ventilator-imposed Work of Breathing
Unusual Coin Lesion in the Lung
Volume 92, Issue 1, Pages (July 1987)
Bedside Calibration Of Pulmonary Artery Catheters
Invasive Pulmonary Aspergillosis
Pulmonary Manifestations in a Case of Multiple Myeloma
Do CIs Give You Confidence?
Effects of Beta-Adrenergic Agents on Hypokalemia
A Single Nasal Prong for Continuous Oxygen Therapy
Theophylline Dose-dumping
Ribavirin in Desquamative Interstitial Pneumonia
Interaction of Rifampin and Glyburide
Volume 42, Issue 2, Pages (August 1962)
Calcification of the Coronary Artery
Volume 140, Issue 1, Pages (July 2011)
Volume 72, Issue 5, Pages (November 1977)
Volume 143, Issue 6, Pages (June 2013)
Counterpoint: Should Medicare Allow Respiratory Therapists to Independently Practice and Bill for Educational Activities Related to COPD? No  Katherine.
Systemic Inflammation, COPD, and Pulmonary Hypertension
New Members of the Editorial Board
Rebuttal From Dr Kollef
John Reid, MD, Donald Cockcroft, MD  CHEST 
Does the Type of Surgical Operation Influence the Changes Observed in Fibrinolytic Activity After Cardiopulmonary Bypass?  J.M. Raya Sanchez, MD, J.M.
Presentation transcript:

Treatment of Cachexia With Ghrelin in Patients With COPD Nagaya Noritoshi , MD, Itoh Takefumi , MD, Murakami Shinsuke , MD, Oya Hideo , MD, Uematsu Masaaki , MD, Miyatake Kunio , MD, Kangawa Kenji , PhD  CHEST  Volume 128, Issue 3, Pages 1187-1193 (September 2005) DOI: 10.1378/chest.128.3.1187 Copyright © 2005 The American College of Chest Physicians Terms and Conditions

Figure 1 Changes in serum GH level after a single administration of ghrelin in patients with COPD. CHEST 2005 128, 1187-1193DOI: (10.1378/chest.128.3.1187) Copyright © 2005 The American College of Chest Physicians Terms and Conditions

Figure 2 Effects of a 3-week administration of ghrelin on food intake (left, A), body weight (middle, B), and lean body mass (right, C). CHEST 2005 128, 1187-1193DOI: (10.1378/chest.128.3.1187) Copyright © 2005 The American College of Chest Physicians Terms and Conditions

Figure 3 Changes in hand-grip strength (left, A), maximal inspiratory pressure (middle, B), and maximal expiratory pressure (right, C) before and after ghrelin therapy. CHEST 2005 128, 1187-1193DOI: (10.1378/chest.128.3.1187) Copyright © 2005 The American College of Chest Physicians Terms and Conditions

Figure 4 Changes in Karnofsky performance status score (left, A) and the distance walked in 6 min (right, B) before and after ghrelin therapy. CHEST 2005 128, 1187-1193DOI: (10.1378/chest.128.3.1187) Copyright © 2005 The American College of Chest Physicians Terms and Conditions

Figure 5 Plasma norepinephrine level before and after ghrelin therapy. CHEST 2005 128, 1187-1193DOI: (10.1378/chest.128.3.1187) Copyright © 2005 The American College of Chest Physicians Terms and Conditions